drugset
drugset / Trial / NCT03793751

Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction

NCT03793751 ↗

Phase 4 Completed 120 enrolled Tata Main Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will aim to identify the impact of Intraoperative dexmedetomidine infusion on POCD assessed by the Montreal Cognitive Assessment (MoCA) in geriatric patients above 60 years undergoing hip surgery under spinal anaesthesia.

Timeline

Start
2017-10-01
Primary completion
2019-12-01
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg —

Indications

cognitive disorder